Log In
Print this Print this

INCB059872, INCB59872

  Manage Alerts
Collapse Summary General Information
Company Incyte Corp.
Description mAb against lysine-specific demethylase 1 (LSD1; KDM1A)
Molecular Target Lysine-specific demethylase 1 (LSD1) (KDM1A)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat advanced cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today